| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0041 | 1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.0064 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |